Kim Kardashian may be famous for her selfies, but the Food and Drug Administration(FDA) wasn’t a fan of her latest one.


An Instagram picture featuring Kardashian, morning sickness drug Diclegis and accompanying text promoting the drug’s benefits garnered more than 450,000 “likes” but brought about a formal FDA warning letter for the drug’s manufacturer.


Part of the letter says, “The social media post is misleading because it presents various efficacy claims for Diclegis, but fails to communicate any risk information.”


The posts promoting the drug have since been taken down, but Kardashian, who was paid to promote the drug, originally claimed it made her feel “a lot better and most importantly, it’s been studied and there was no increased risk to the baby.